EDEN PRAIRIE, Minn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced ...
VANCOUVER, B.C.—An overhydration (OH) index derived from spectroscopic bioimpedance may help guide ultrafiltration in hemodialysis (HD) patients and the modification of their antihypertensive therapy, ...
Tirzepatide significantly reduces cardiovascular death or worsening heart failure risk by 38% in patients with obesity-related HFpEF. The drug improves blood pressure, inflammation, and volume ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback